NO20043698L - Kombinasjonspreparat av natrium-hydrogenbytteinhibitoren cariporid med ACE-inhibitorer for prevensjon av hjertesvikt og andre aldersrelaterte dysfunksjoner i organer, aldersrelaterte sykdommer og for forlenget levetid - Google Patents

Kombinasjonspreparat av natrium-hydrogenbytteinhibitoren cariporid med ACE-inhibitorer for prevensjon av hjertesvikt og andre aldersrelaterte dysfunksjoner i organer, aldersrelaterte sykdommer og for forlenget levetid

Info

Publication number
NO20043698L
NO20043698L NO20043698A NO20043698A NO20043698L NO 20043698 L NO20043698 L NO 20043698L NO 20043698 A NO20043698 A NO 20043698A NO 20043698 A NO20043698 A NO 20043698A NO 20043698 L NO20043698 L NO 20043698L
Authority
NO
Norway
Prior art keywords
age
organs
heart failure
sodium hydrogen
ace inhibitors
Prior art date
Application number
NO20043698A
Other languages
English (en)
Inventor
Wolfgang Linz
Ursula Schindler
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20043698L publication Critical patent/NO20043698L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20043698A 2002-02-04 2004-08-31 Kombinasjonspreparat av natrium-hydrogenbytteinhibitoren cariporid med ACE-inhibitorer for prevensjon av hjertesvikt og andre aldersrelaterte dysfunksjoner i organer, aldersrelaterte sykdommer og for forlenget levetid NO20043698L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10204571 2002-02-04
PCT/EP2003/000587 WO2003066045A1 (de) 2002-02-04 2003-01-22 Kombinationspräparat des natrium-wasserstoff-austauch-inhibitors cariporide mit ace-hemmern zur verhinderung der herzinsuffizienz und anderer altersbedingter organ-dysfunktionen, altersbedingter erkrankungen und zur lebensverlängerung

Publications (1)

Publication Number Publication Date
NO20043698L true NO20043698L (no) 2004-08-31

Family

ID=27674558

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043698A NO20043698L (no) 2002-02-04 2004-08-31 Kombinasjonspreparat av natrium-hydrogenbytteinhibitoren cariporid med ACE-inhibitorer for prevensjon av hjertesvikt og andre aldersrelaterte dysfunksjoner i organer, aldersrelaterte sykdommer og for forlenget levetid

Country Status (23)

Country Link
EP (1) EP1474134B1 (no)
JP (1) JP4733348B2 (no)
KR (1) KR20040083498A (no)
CN (1) CN1319528C (no)
AR (1) AR038387A1 (no)
AT (1) ATE520398T1 (no)
AU (1) AU2003244430A1 (no)
BR (1) BR0307443A (no)
CA (1) CA2474888A1 (no)
CO (1) CO5601009A2 (no)
HR (1) HRP20040702A2 (no)
HU (1) HUP0402593A2 (no)
MA (1) MA27170A1 (no)
MX (1) MXPA04007569A (no)
NO (1) NO20043698L (no)
NZ (1) NZ534479A (no)
PE (1) PE20040188A1 (no)
PL (1) PL370488A1 (no)
RS (1) RS68204A (no)
RU (1) RU2004126702A (no)
TW (1) TW200306850A (no)
WO (1) WO2003066045A1 (no)
ZA (1) ZA200406066B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG184353A1 (en) * 2010-03-31 2012-11-29 Hospital For Sick Children Use of remote ischemic conditioning to improve outcome after myocardial infarction

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0855392A3 (de) * 1997-01-22 2000-01-05 Hoechst Aktiengesellschaft Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19734693A1 (de) * 1997-08-11 1998-01-22 Hoechst Marion Roussel De Gmbh Verwendung von Cariporide als Inhibitor des zellulären NA+/H+-Exchangers (NHE) zur Herstellung eines Medikaments zur Behandlung von cardialen und nichtcardialen Krankheiten
DE19737224A1 (de) * 1997-08-27 1999-03-18 Hoechst Marion Roussel De Gmbh Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
DE19859727A1 (de) * 1998-12-23 2000-06-29 Aventis Pharma Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung

Also Published As

Publication number Publication date
JP4733348B2 (ja) 2011-07-27
AR038387A1 (es) 2005-01-12
RU2004126702A (ru) 2005-04-20
MA27170A1 (fr) 2005-01-03
JP2005519072A (ja) 2005-06-30
EP1474134A1 (de) 2004-11-10
WO2003066045A1 (de) 2003-08-14
CA2474888A1 (en) 2003-08-14
CN1694697A (zh) 2005-11-09
NZ534479A (en) 2006-03-31
MXPA04007569A (es) 2004-11-01
RS68204A (sr) 2007-02-05
CN1319528C (zh) 2007-06-06
PE20040188A1 (es) 2004-05-17
ZA200406066B (en) 2005-06-08
PL370488A1 (en) 2005-05-30
BR0307443A (pt) 2005-01-04
HRP20040702A2 (en) 2005-04-30
TW200306850A (en) 2003-12-01
ATE520398T1 (de) 2011-09-15
KR20040083498A (ko) 2004-10-02
EP1474134B1 (de) 2011-08-17
CO5601009A2 (es) 2006-01-31
AU2003244430A1 (en) 2003-09-02
HUP0402593A2 (hu) 2005-04-28

Similar Documents

Publication Publication Date Title
MXJL06000006A (es) Derivados de naftiridina sustituidos como inhibidores del factor inhibidor de la migracion de macrofagos y su uso en el tratamiento de enfermedades en el hombre.
WO2007109251A3 (en) Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
EA201391705A1 (ru) Триазолпиридиновые ингибиторы 11-бета-гидроксистероиддегидрогеназы типа i
EA200802329A1 (ru) Производные триазола ii
DK1753748T3 (da) Prolinderivater og deres anvendelse som dipeptidyl-peptidase-IV-inhibitorer
DK1956004T3 (da) Quinolinderivater og deres anvendelse som 5-HT6-ligander
NO20053356L (no) Aminindazolderivater og anvendelse derav som kinaseinhibitorer.
EA200870091A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для снятия боли
NO20043580L (no) Quinazolinonderivater og deres bruk som CB agonister
DK1442023T3 (da) Krystallinsk natriumsalt af telmisartan og anvendelse af dette som angiotensinantagonist
NO20075662L (no) Roflumilast for behandlingen av pulmonal hypertensjon
ECSP055844A (es) Nuevos compuestos triciclicos
NO20065079L (no) Materialer og metoder for behandling av koaguleringssykdommer
DK1505871T3 (da) Konservering af rna og morfologi i celler og væv
SG156681A1 (en) Use of ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
EA200501557A1 (ru) Новый способ синтеза (2s)-индолин-2-карбоновой кислоты и использование в синтезе периндоприла
NO20070250L (no) S-Tenatoprazol-natriummonohydratsalt og dennes anvendelse i form av en protonpumpe-inhibitor
NO20013145L (no) Anvendelse av inhibitorer av natriumhydrogenutbytteren for fremstilling av et medikament for prevensjon av organdysfunksjonerog -sykdommer relatert en spesiell alder og for a forlengelevetiden
DE60301862D1 (de) Kombinationsbehandlung bei akutem myokardinfarkt
DE60305053D1 (de) Pyrimidinderivate als selektive cox-2-inhibitoren
NO20054216L (no) Anvendelse av dipyridamol i kombinasjon med acetylsalisylsyre og en angiotensin II antagonist for forhindring av slag
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
ATE510543T1 (de) Verwendung cilobradines oder seiner pharmazeutisch annehmbaren salze für die behandlung oder prävention von herzinsuffizienz
BR0312712A (pt) Aminoácido modificado para a inibição da agregação plaquetária
DE602004002964D1 (de) 7-azaindolderivate als cox2-inhibitoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application